Magellan Rx Specialty Pharmacy Helps More Patients Achieve Adherence Goals through MRx Cares Clinical Coaching Program
September 05 2019 - 6:30AM
Business Wire
Magellan Rx Management, the pharmacy benefit management (PBM)
division of Magellan Health, Inc. (NASDAQ: MGLN), today announced
superior outcomes for members receiving specialty medications
through MRx Specialty Pharmacy. Compared to benchmarks, members who
utilize MRx Specialty Pharmacy were significantly more likely to
reach and maintain adherence goals of 85 percent or greater –
measured by proportion of days covered (PDC) - across all disease
states.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190905005115/en/
Source: 2019 Magellan Rx internal
data
A key component to the success of MRx Specialty Pharmacy is its
MRx Cares program, a one-on-one clinical coaching program that
provides expert care for those managing complex specialty
conditions. In a recent survey, 97 percent of members reported that
the MRx Cares program was able to improve the way they manage their
medication, and results show an overall satisfaction rate of 99
percent, citing health coach professionalism, knowledge, and
supportiveness as key factors.
Improving health through engagement, motivational
interviewing, and targeted education
While medication adherence is important for all patients, the
impact of non-adherence on a specialty patient can be magnified due
to the costs and complexities of treatment, especially when
accompanied by another chronic condition. Non-adherence to
essential medications is a frequent cause of preventable
hospitalizations and patient illness, with estimated costs to the
U.S. healthcare system of greater than $300 billion annually.2
In addition to the superior care that members receive when they
fill their specialty medication with MRx Specialty Pharmacy,
members also have the opportunity to engage with the MRx Cares
program as part of MRx Specialty Pharmacy’s services. This program
leverages cutting-edge technology and the company’s behavioral
health expertise to improve clinical outcomes for members. Nurses
are provided with intensive training in Motivational
Interviewing-based health coaching (MIHC) techniques that are
designed to help overcome emotional barriers by enhancing member
understanding of their condition and improving adherence,
uncovering the internal motivation needed to positively change
behavior.
Each year, specially-trained nurses complete thousands of
targeted clinical consultations aimed at helping patients better
manage complex and high-cost specialty diseases. Patients offered
these consultations demonstrated higher adherence rates across
specialty diseases such as multiple sclerosis, HIV, rheumatoid
arthritis, oncology, and hepatitis C. Better adherence rates have
been associated with improved disease control, a reduction in
negative health outcomes, overall cost avoidance, and an
improvement in total healthcare costs.
“We are energized by the results we’ve seen with MRx Specialty
Pharmacy and its ability to provide members with the support they
need to stay adherent and, ultimately, experience better health
outcomes,” said Haita Makanji, vice president of clinical strategy
and innovation, Magellan Rx Management. “In addition, members who
participate in the MRx Cares program continue to gain access to our
Motivational Interviewing-based interventions and digital tools,
like text messaging and video streaming. We look forward to
expanding to other disease states such as organ transplant, which
was introduced earlier this year.”
Accredited by URAC and ACHC, MRx Specialty Pharmacy leverages a
highly sophisticated, integrated drug distribution system, enhanced
by a large array of limited distribution drugs available across all
disease states, to help members manage their complex conditions and
improve overall quality of life. Through a high-touch, high-tech
clinical model that utilizes on-demand educational videos, patient
texting capabilities, and video calls with dedicated pharmacists
and nursing support, MRx Specialty Pharmacy drives better adherence
and optimizes patient outcomes through programs such as MRx
Cares.
To learn more about MRx Specialty Pharmacy’s one-on-one clinical
coaching program, MRx Cares, watch this 14-minute webinar.
- Internal data from MRx PBM claims, 2019.
- PCMA. PBM Specialty Pharmacies Improve Patient Outcomes and
Reduce Costs. Accessed 9 May 2019.
About Magellan Rx Management: Magellan Rx Management, a
division of Magellan Health, Inc., is a full-service,
next-generation pharmacy benefit manager (PBM) that helps our
customers and members solve complex pharmacy challenges by
connecting them to the people, technology, and information they
need to make smarter healthcare decisions. As experts in managing
specialty spend both on the prescription and medical benefit, we
are energized by discovering new and better ways to deliver
solutions in today’s complex and rapidly-evolving healthcare
environment, leading people to live healthier, more vibrant
lives.
About Magellan Health: Magellan Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through
technology, while remaining focused on the critical personal
relationships that are necessary to achieve a healthy, vibrant
life. Magellan's customers include health plans and other managed
care organizations, employers, labor unions, various military and
governmental agencies and third-party administrators. For more
information, visit MagellanHealth.com.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190905005115/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923 Investor Contact: Joe Bogdan,
jbogdan@magellanhealth.com, (860) 507-1910
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Apr 2023 to Apr 2024